Author details

Full Name

Christof M Kramm

Affiliation

ORCID

Career Start Year

1991

Papers

163

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37875569	Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.	Nat Med	2024
36720762	How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study.		2023
36437415	Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-isÂ a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.	Acta Neuropathol	2023
37770435	RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer.		2023
37182140	Optimizing the structure of interdisciplinary tumor boards for effective cancer care.		2023
36928815	Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.	Nat Med	2023
36786841	Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-isÂ a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.	Acta Neuropathol	2023
35012690	Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival.	Acta Neuropathol Commun	2022
35446794	SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome.	Am J Surg Pathol	2022
36162411	DIPG- Very Long-Term Survivors - are There Factors Which May Predict a Better Outcome?	Klinische Padiatrie	2022
35814457	Neurological Symptom Improvement After Re-Irradiation in Patients With Diffuse Intrinsic Pontine Glioma: A Retrospective Analysis of the SIOP-E-HGG/DIPG Project.	Front Oncol	2022
36077842	A microRNA Prognostic Signature in Patients with Diffuse Intrinsic Pontine Gliomas through Non-Invasive Liquid Biopsy.	Cancers (Basel)	2022
36137663	MR Imaging and Clinical Characteristics of Diffuse Glioneuronal Tumor with Oligodendroglioma-like Features and Nuclear Clusters.	AJNR Am J Neuroradiol	2022
35802025	FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits.	Cancer Res	2022
35733513	Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates.	Neurooncol Adv	2022
36575299	Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.	NPJ Precis Oncol	2022
34919158	Magnetic Resonance Imaging Characteristics of Molecular Subgroups in Pediatric H3Â K27M Mutant Diffuse Midline Glioma.	Clinical Neuroradiology	2022
34417833	PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.	Acta Neuropathol	2021
33942498	Complementary and alternative medicine in children with diffuse intrinsic pontine glioma-A SIOPE DIPG Network and Registry study.	Pediatric Blood and Cancer	2021
33130881	A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR.	Neuro Oncol	2021
32619305	Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?	Brain Pathol	2021
33216206	Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.	Acta Neuropathol	2021
33398909	Chondrodysplasia and growth failure in children after early hematopoietic stem cell transplantation for non-oncologic disorders.	Am J Med Genet A	2021
34845197	Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.	Cell Death and Disease	2021
34545083	Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B.	Nat Commun	2021
34373263	The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets.	Cancer Discov	2021
34704035	Spontaneous regression of a congenital high-grade glioma-a case report.	Neurooncol Adv	2021
34595479	Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumors.	Neurooncol Adv	2021
34536122	GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.	Acta Neuropathol	2021
31431735	Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma.	Leukemia	2020
32193787	Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation.	Acta Neuropathol	2020
32238360	Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes.	Cancer Discov	2020
31756732	Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro.	Pediatric Research	2020
33260742	Spinal Deformities after Childhood Tumors.	Cancers	2020
33259802	Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.	Cell	2020
32826850	Combined treatment with CBP and BET inhibitors reverses inadvertent activation of detrimental super enhancer programs in DIPG cells.	Cell Death and Disease	2020
30945122	Impact of rs12917 MGMT Polymorphism on [F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL).	Molecular Imaging and Biology	2019
30525761	The use of Do-Not-Resuscitate-Order equivalents in pediatric palliative care medicine in Germany.	Annals of palliative medicine	2019
30652419	Desmoplastic small round cell tumors: Multimodality treatment and new risk factors.	Cancer Med	2019
31522324	Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?	J Neurooncol	2019
30693642	Occurrence of high-grade glioma in Noonan syndrome: Report of two cases.	Pediatr Blood Cancer	2019
31022591	Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience.	Eur J Cancer	2019
30850560	Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.	Oncologist	2019
31379802	The German National Registry of Primary Immunodeficiencies (2012-2017).	Front Immunol	2019
31109382	H3F3A-G34R mutant high grade neuroepithelial neoplasms with glial and dysplastic ganglion cell components.	Acta Neuropathol Commun	2019
29539639	DNA methylation-based classification of central nervous system tumours.	Nature	2018
29016894	Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.	Neuro Oncol	2018
29022050	Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with aÂ cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients.	Strahlentherapie und Onkologie	2018
30159736	Correction to: A suggestion to introduce the diagnosis of "diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)".	Acta Neuropathologica	2018
30396367	Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location.	Acta Neuropathol Commun	2018